"Dean, I am very grateful to the school and college for taking care of me during this time. I want to apply to withdraw from school."
The first thing he did after reaching a venture capital agreement with Lei Jun was to take a break from school. Diplomas and academic qualifications were worthless to him.
After it was proven that the spellcasting path was feasible and magic could be reproduced in this world, the most important thing for Zheng Li was to obtain enough resources to restore his spellcasting ability.
If the experiment of consciousness interfering with reality fails, Zheng Li may still be willing to hibernate at Jiangcheng University for a while.
Dean Zhao was shocked. It was understandable that he would drop out of school if he couldn't study well. There were people who dropped out of school every year in the School of Mathematics.
Jiangcheng University has grade point requirements for students to change majors. Students who do not meet the grade point requirements cannot change majors. And if you can't study mathematics, you won't be able to meet the grade point requirements for changing majors. This is an endless cycle.
And who is Zheng Li? Now the outside media has promoted him as a rare genius in Jiangcheng University in a hundred years. His reputation is second only to Lei Jun who was born in Jiangcheng University.
Dean Zhao cannot understand that the top genius who has just published in Nature and ARMA is dropping out of school.
Dean Zhao asked: "Why?"
"Is it because a foreign school has given you an olive branch?"
Although it is rare but not unheard of to study in a university in China for one or two years and then transfer to a foreign country if you are dissatisfied with university life.
Especially for a top talent like Zheng Li, prestigious foreign schools will not be stingy with scholarships.
Zheng Li shook his head: "No, although professors from Harvard, Yale, and Stanford have sent me emails telling me that I can go directly to graduate school, I didn't agree."
"I just have more important things to do."
If an ordinary student comes to drop out, Dean Zhao will ask him to go to the staff to go through the formalities after a few words. Zheng Li showed that he is too talented, so Dean Zhao asked:
"What's more important?"
Zheng Li: "I went to Yanjing yesterday to meet Lei Jun from Da Mi. He promised to give me 50 million in venture capital. I couldn't balance my studies and starting a business, so I applied to drop out of school."
Extraordinary people do extraordinary things. Dean Zhao only had this idea in his mind. He originally wanted to say that studying hard would have greater development prospects than starting a business.
But then I thought about it, it wasn’t necessary.
If you don't follow the path of scientific research, 50 million in venture capital will be far more than you can learn in school. Students graduating from Jiangcheng University will earn less than 1% of 50 million on their own in a lifetime.
Dean Zhao said: "How many shares are fifty million?"
Zheng Li: "Fifty million and 10% of the shares are just the first round of venture capital."
The dean of the School of Mathematics calculated the company's valuation in less than a second: "It's amazing. He received 50 million in venture capital at the age of eighteen."
"Then your company has reached 500 million without a single valuation, and your shares account for 90%, which is 450 million."
"It's amazing!"
"If you look at today's celebrities, the teacher is happy for you."
"But don't drop out of school in a hurry. The college will help you retain your student status. It's considered a one-year break. If the business doesn't go well, you can come back and continue your studies."
"The teacher believes you can succeed, but he also hopes you will leave yourself a way out."
"Shuyuan will always be your home."
Dean Zhao does not object to Zheng Li's entrepreneurial venture. If the venture is successful, then the School of Mathematical Sciences will have entrepreneurial alumni, which will be a positive thing for the School of Mathematical Sciences. Maybe there will be alumni donating scholarships.
If the business fails, then Zheng Li will come back to continue his studies honestly, and the Institute of Mathematics will have a talented mathematician.
No matter what, it's not a loss from his point of view.
The biggest loss was that he dropped out of school, and then Zheng Li failed to start his own business and went to another school to study. He couldn't get anything out of the math school.
"good."
...
"What!!!" Li Miaomiao couldn't understand why he suddenly had to drop out of school.
"I contacted Lei Jun from Rice the day before yesterday, and then I went to Yanjing to meet him yesterday. He was willing to invest 50 million in me as start-up capital." Zheng Li said.
"I plan to drop out of school and start a business."
If someone told her about 50 million venture capital, she would think they were joking. But Zheng Li was different. Li Miaomiao knew that Zheng Li never joked.
With Zheng Li's ability, this may not be impossible. Li Miaomiao asked: "Where do you start a business? Jiangcheng or Yanjing?"
Zheng Li: "In the high-tech park in Suzhou, the members of my team are basically the people Mr. Lei helped me find. They chose Suzhou."
"Susu is the core area of the Yangtze River Delta. The direction of my business is biomedicine. There are many innovative pharmaceutical companies in the Yangtze River Delta and the talent pool is complete."
"In addition, Suzhou's high-tech parks will have many tax incentives."
Li Miaomiao became depressed. She had an inexplicable feeling that her feelings would end before they even started. She suppressed her emotions and asked:
"If you are starting a business in biomedicine, 50 million is not enough to start."
"For any new drug, even if we outsource R&D to a foreign company, a starting price of RMB 50 million is not enough."
Many domestic pharmaceutical companies claim to be producing innovative drugs, but in fact they are outsourcing research and development for European and American pharmaceutical companies, because labor costs and water and electricity costs in China are much lower than abroad.
Trivia: In 2018, my friend’s company recruited a Ph.D. in Biology who graduated from Fudan University (his undergraduate degree was not double non-fei, and his undergraduate degree was also 211). The annual salary was about 220,000 to 250,000, and he was located in Shanghai. In Europe and the United States, a doctorate with the same background would cost at least 80,000 to 100,000 yuan.
Zheng Li: "Do you know what the topic of my nature thesis is?"
Li Miaomiao: "Synthetic endorphins. I don't know how many times my dad recited it in my ears when I went home over the weekend."
Zheng Li: "I also invented a method for large-scale production of endorphins. Fifty million is just the price of registering a worldwide patent and clinical phase I experiments."
“When the results of the first phase of clinical trials come out, we will conduct a second round of venture capital investment.”
Li Miaomiao: "No wonder Lei Jun invested 50 million RMB without hesitation."
"If you have the technology in hand, then the price of 50 million is not expensive at all."
"Fifty million and he holds the majority share?"
Zheng Li: "Ten percent."
Li Miaomiao: "That's okay. In the next two, three or even more rounds of venture capital, your shares will not be diluted too much."
"I suggest you try to introduce as much international capital as possible for your second round of investment, such as IDG, European and American investment institutions, etc."
"Endorphins are a drug with great promise. If you want to sell it all over the world, like American, you need to obtain its FDA authorization."
"If you don't have European and American capital, clinical trials and authorization will take a long time."
"If you want to be an international R&D pharmaceutical company, appropriately introducing some European and American capital will not only help you open up their market, but also help you introduce first-line European and American researchers."
Zheng Li: "I don't see that you have quite a lot of research on the pharmaceutical industry."
